{"id":"W4385297223","doi":"10.1016/s2468-1253(23)00197-8","title":"Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study","year":2023,"lang":"en","type":"article","venue":"˜The œLancet. Gastroenterology & hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":404,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Cilag; Pan American Health Organization; Genentech; National Institutes of Health; National Science and Technology Council; Norgine; AOP Orphan; Ipsen; European Association for the Study of the Liver; Janssen Pharmaceuticals; Angelini Pharma; Shionogi; State Government of Victoria; Swedish Orphan Biovitrum; Novo Nordisk; Astellas Pharma; Eisai; Alexion Pharmaceuticals; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Pfizer; European Centre for Disease Prevention and Control; Boston Scientific Corporation; Stiftung für Leberkrankheiten; Asociación Española para el Estudio del Hígado; Alnylam Pharmaceuticals; National Cancer Institute; Gilead Sciences; National Institute of Allergy and Infectious Diseases; Australian Government; Indivior; World Health Organization; GlaxoSmithKline; Abbott Laboratories; CSL Behring; Allergan; AstraZeneca; Bristol-Myers Squibb; Eli Lilly and Company; Canadian Association for the Study of the Liver; Amgen; Intercept Pharmaceuticals; National Science Foundation","keywords":"Cascade; Medicine; Virology; Environmental health; Internal medicine; Engineering","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02201717143091481,"score_gpt":0.2864098978668558,"score_spread":0.264392726435941,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}